Latest Management of ulcerative colitis Stories
MIAMI LAKES, Fla., Nov.
FREIBURG and HEIDELBERG, Germany, October 29, 2014 /PRNewswire/ -- Positive FDA feedback on the protocol for the US Phase III trial with LT-02,
Company Recently Initiated Phase II in Bullous Pemphigoid CAMBRIDGE, Mass. and HERZLIYA PITUACH, Israel, Sept. 18, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc.
Mucosal Healing and Maintenance of Remission Have High Influence in Gastroenterologists' Prescribing Decision for UC, According to Findings from Decision Resources Group BURLINGTON, Mass.,
OKLAHOMA CITY, Feb.
OKLAHOMA CITY, Jan.
A drug currently on the market to treat leukemia reversed symptoms of colitis in lab tests.
Patients receiving radiotherapy (RT) for cancers in the pelvic region can experience diarrhea, a negative side effect of radiation treatment.
Vedolizumab, a new intravenous antibody medication, has shown positive results for treating both Crohn's disease and ulcerative colitis.
Achieve Clinical Research is conducting a randomized clinical study to evaluate the safety, tolerability, and efficacy of a new drug in subjects with moderate to severe
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.